Efficacy and Safety of Intravenous Ferric Carboxymaltose in Geriatric Inpatients at a German Tertiary University Teaching Hospital: A Retrospective Observational Cohort Study of Clinical Practice

Table 2

Baseline iron parameters of all patients aged >75 years, subdivided into age groups.

Age group	Number of patients	Hb (g/dL)	Ferritin (µg/L)	TSAT (%)	CRP (mg/dL)
		mean ± SD	mean ± SD	mean ± SD	mean ± SD
		(median; min–max)	(median; min–max)	(median; min–max)	(median; min–max)
76–85 years	17	10.42 ± 0.85	194.52 ± 144.49	9.59 ± 3.71	7.16 ± 10.33
		(10.3; 8.8–11.8)	(160.0; 21–714)	(10.00; 4–17)	(4.1; 0.2–49.0)
>85 years	21	11.00 ± 1.52	255.42 ± 208.64	9.6 ± 2.78	5.49 ± 7.03
		(10.7; 8.8–13.5)	(163.0; 29–796)	(10.00; 5–10)	(3.6; 0.2–28.7)
All	38	10.74 ± 1.30	228.2 ± 185.24	9.61 ± 3.23	6.41 ± 9.04
		(10.5; 8.8–13.5)	(161.50; 21–796)	(9.6; 4–17)	(3.9; 0.2–49.0)